Der Urologe. Ausg. A
-
Der Urologe. Ausg. A · Jul 2011
Review[Metastatic renal cell carcinoma: therapeutic concepts for non-medicinal treatment].
Metastatic renal cell carcinoma has a poor prognosis with a median overall survival rate of approximately 2 years. The current standard medicinal therapy includes the use of tyrosine kinase inhibitors or antiangiogenic substances, such as VEGF receptor antagonists. ⋯ Additionally, complete resection of solitary or at least a limited number of metastases can potentially be done with curative intent. Radiotherapy remains the standard procedure for palliative therapy of brain metastases to reduce clinical symptoms and to improve intracerebral tumor control.